Literature DB >> 4389278

The monoamine oxidase catalyzed degradation of phenelzine-l-14C, an irreversible inhibitor of monoamine oxidase--I. Studies in vitro.

B V Clineschmidt, A Horita.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4389278     DOI: 10.1016/0006-2952(69)90104-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  14 in total

Review 1.  Neurochemical and metabolic aspects of antidepressants: an overview.

Authors:  G B Baker; R T Coutts; A J Greenshaw
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

Review 2.  Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review.

Authors:  G B Baker; R T Coutts; K F McKenna; R L Sherry-McKenna
Journal:  J Psychiatry Neurosci       Date:  1992-11       Impact factor: 6.186

3.  The myth of phenelzine acetylation.

Authors:  E F Marshall
Journal:  Br Med J       Date:  1976-10-02

4.  The reaction of monoamine oxidase with phenethylhydrazine.

Authors:  K F Tipton
Journal:  Biochem J       Date:  1971-02       Impact factor: 3.857

5.  Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.

Authors:  Erin M MacKenzie; Suzanne L Grant; Glen B Baker; Paul L Wood
Journal:  Neurochem Res       Date:  2007-08-31       Impact factor: 3.996

6.  Inhibition of monoamine oxidase by substituted hydrazines.

Authors:  K F Tipton
Journal:  Biochem J       Date:  1972-07       Impact factor: 3.857

7.  The kinetics of phenethylhydrazine oxidation by monoamine oxidase.

Authors:  K F Tipton; I P Spires
Journal:  Biochem J       Date:  1971-11       Impact factor: 3.857

8.  Purification and properties of the trimethylamine dehydrogenase of bacterium 4B6.

Authors:  J Colby; L J Zatman
Journal:  Biochem J       Date:  1974-12       Impact factor: 3.857

9.  Urinary excretion of bioactive amines and their metabolites in psychiatric patients receiving phenelzine.

Authors:  K F McKenna; G B Baker; R T Coutts
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

10.  Potentiation of the behavioural effects of the antidepressant phenelzine by deuterium substitution.

Authors:  C T Dourish; K M Dewar; L E Dyck; A A Boulton
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.